[Federal Register Volume 67, Number 85 (Thursday, May 2, 2002)]
[Notices]
[Page 22090]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-10797]



[[Page 22090]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Technical Electronic Products Radiation Safety Standards 
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces a forthcoming meeting of a public 
advisory committee of the Food and Drug Administration (FDA). The 
meeting will be open to the public.
    Name of Committee: Technical Electronic Products Radiation Safety 
Standards Committee.
    General Function of the Committee: To provide advice on technical 
feasibility, reasonableness, and practicality of performance standards 
for electronic products to control the emission of radiation under 21 
U.S.C. 360kk(f).
    Date and Time: The meeting will be held on May 22, 2002, from 8:30 
a.m. to 5 p.m.
    Location: Hilton Washington DC North/Gaithersburg, Salons A and B, 
620 Perry Pkwy., Gaithersburg, MD.
    Contact Person: Orhan H. Suleiman, Center for Devices and 
Radiological Health (HFZ-240), Food and Drug Administration, 1350 
Piccard Dr., Rockville, MD 20850, 301-594-3332, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12399. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The committee will hear an informal review of ongoing 
activities associated with electronic products. Following the overview, 
FDA will discuss its concern about radiation doses associated with x-
ray computed tomography (CT), and its current thinking about amending 
the U.S. performance standard for x-ray CT imaging procedures. 
Specifically FDA will address possible requirements for: (1) Definition 
and standardization of CT terminology; (2) display of an index of 
patient radiation dose that could be automatically recorded within a 
facility quality assurance program; (3) automatic exposure control 
through modulation of x-ray tube output according to patient 
dimensions; and (4) limitation of the x-ray field size to that needed 
for image formation. In the afternoon, FDA will discuss proposed 
amendments to the U.S. performance standard for sunlamp products and 
certain initiatives of international standards organizations concerning 
sunlamp products. In the final session, FDA will be considering 
mandatory standards for x-ray security screening systems; FDA will 
discuss public health considerations regarding these systems that use 
ionizing radiation.
    Background information on the discussion topics will be posted 
under the Technical Electronic Products Radiation Safety Standards 
Committee (TEPRSSC) Dockets Management Branch Web site at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm. (Click on the year 2002 and 
scroll down to TEPRSSC.)
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by May 10, 2002. 
On May 22, 2002, oral presentations from the public will be scheduled 
between approximately 9:45 a.m. and 10:15 a.m., and between 3:15 p.m. 
and 4 p.m. Time allotted for each presentation may be limited. Those 
desiring to make formal oral presentations should notify the contact 
person before May 10, 2002, and submit a brief statement of the general 
nature of the evidence or arguments they wish to present, the names and 
addresses of proposed participants, and an indication of the 
approximate time requested to make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact AnnMarie Williams, 
Conference Management Staff, 301-594-1283, ext. 113, at least 7 days in 
advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: April 24, 2002.
Linda A. Suydam,
Senior Associate Commissioner for Communications and Constituent 
Relations.
[FR Doc. 02-10797 Filed 5-1-02; 8:45 am]
BILLING CODE 4160-01-S